Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain

NCT00214942 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Chronic Low Back Pain

Interventions

DRUG: ORAVESCENT Fentanyl Citrate

Sponsor

Cephalon